🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s TECH Holdings & Trades

First Buy
Q4 2014
Duration Held
41 Quarters
Largest Add
Q4 2014
+2.11 M Shares
Current Position
12,900 Shares
$934,863 Value

Renaissance Technologies (RenTech)'s TECH Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 12,900 shares of Bio-Techne Corporation (TECH) worth $934,863, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 710,080 shares. Largest reduction occurred in Q1 2015, reducing 982,400 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Bio-Techne Corporation (TECH) Holding Value Over Time

Track share changes against reported price movement

Quarterly Bio-Techne Corporation (TECH) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +12,900 New Buy 12,900 $72.47
Q3 2025 -590,700 Sold Out 0 $0.00
Q2 2025 +446,300 Add 309.07% 590,700 $51.45
Q1 2025 +144,400 New Buy 144,400 $58.63
Q4 2023 -258,326 Sold Out 0 $0.00
Q3 2023 +178,526 Add 223.72% 258,326 $68.07
Q2 2023 -379,900 Reduce 82.64% 79,800 $0.08
Q1 2023 +41,300 Add 9.87% 459,700 $0.07
Q4 2022 -665,376 Reduce 61.39% 418,400 $0.08
Q3 2022 +498,976 Add 85.32% 1.08 M $71.00
Q2 2022 +455,600 Add 352.63% 584,800 $86.66
Q1 2022 +92,400 Add 251.09% 129,200 $108.26
Q4 2021 +26,000 Add 240.74% 36,800 $129.35
Q3 2021 -23,600 Reduce 68.60% 10,800 $121.11
Q2 2021 -108,208 Reduce 75.88% 34,400 $112.56
Q1 2021 -513,244 Reduce 78.26% 142,608 $95.49
Q4 2020 -598,048 Reduce 47.70% 655,852 $79.39
Q3 2020 -306,800 Reduce 19.66% 1.25 M $61.93
Q2 2020 -386,580 Reduce 19.85% 1.56 M $66.02
Q1 2020 -77,324 Reduce 3.82% 1.95 M $47.41
Q4 2019 -243,876 Reduce 10.75% 2.02 M $54.88
Q3 2019 +379,200 Add 20.07% 2.27 M $48.92
Q2 2019 -72,000 Reduce 3.67% 1.89 M $52.12
Q1 2019 -523,600 Reduce 21.07% 1.96 M $49.64
Q4 2018 +710,080 Add 40.01% 2.48 M $36.18
Q3 2018 +119,600 Add 7.23% 1.77 M $51.03
Q2 2018 +174,000 Add 11.75% 1.66 M $36.99
Q1 2018 +57,200 Add 4.02% 1.48 M $37.76
Q4 2017 +445,200 Add 45.48% 1.42 M $32.39
Q3 2017 +390,400 Add 66.35% 978,800 $30.22
Q2 2017 -166,000 Reduce 22.00% 588,400 $29.37
Q1 2017 +28,400 Add 3.91% 754,400 $25.41
Q4 2016 +152,000 Add 26.48% 726,000 $25.71
Q3 2016 +414,800 Add 260.55% 574,000 $27.37
Q2 2016 -257,200 Reduce 61.77% 159,200 $28.19
Q1 2016 -222,800 Reduce 34.86% 416,400 $23.63
Q4 2015 -342,400 Reduce 34.88% 639,200 $22.50
Q3 2015 +200,000 Add 25.59% 981,600 $23.12
Q2 2015 -342,800 Reduce 30.49% 781,600 $24.62
Q1 2015 -982,400 Reduce 46.63% 1.12 M $25.07
Q4 2014 +2.11 M New Buy 2.11 M $23.10

Renaissance Technologies (RenTech)'s Bio-Techne Corporation Investment FAQs

Renaissance Technologies (RenTech) first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 2,106,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Bio-Techne Corporation (TECH) for 41 quarters since Q4 2014.

Renaissance Technologies (RenTech)'s largest addition to Bio-Techne Corporation (TECH) was in Q4 2014, adding 2,106,800 shares worth $48.67 M.

According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 12,900 shares of Bio-Techne Corporation (TECH), valued at approximately $934,863.

As of the Q3 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Bio-Techne Corporation (TECH) was 2,484,880 shares, as reported at the end of Q4 2018.